Indications
The Vitrasert implant is indicated for the local treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) (See 4.4. Special warnings and special precautions for use).
Composition
- Active substance
- ganciclovir
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Vitrasert Implant
- Active substance
- ganciclovir
- ATC code
- J05AB06
- Therapeutic area
- Cytomegalovirus Retinitis, HIV Infections
- Marketing authorisation holder
- Dr. Gerhard Mann, Chem.-Pharm. Fabrik GmbH..
- Status